E
69.78
-0.08 (-0.11%)
| Previous Close | 69.86 |
| Open | 69.96 |
| Volume | 4,326,130 |
| Avg. Volume (3M) | 5,012,626 |
| Market Cap | 41,156,243,456 |
| Price / Earnings (TTM) | 26.94 |
| Price / Earnings (Forward) | 28.82 |
| Price / Sales | 6.67 |
| Price / Book | 4.31 |
| 52 Weeks Range | |
| Earnings Date | 4 Feb 2025 - 10 Feb 2025 |
| Profit Margin | 65.86% |
| Operating Margin (TTM) | 29.11% |
| Diluted EPS (TTM) | 2.59 |
| Quarterly Revenue Growth (YOY) | 8.90% |
| Quarterly Earnings Growth (YOY) | 697.80% |
| Total Debt/Equity (MRQ) | 7.35% |
| Current Ratio (MRQ) | 3.46 |
| Operating Cash Flow (TTM) | 806.40 M |
| Levered Free Cash Flow (TTM) | 1.79 B |
| Return on Assets (TTM) | 10.65% |
| Return on Equity (TTM) | 19.14% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Edwards Lifesciences Corporatio | Bearish | Bearish |
AIStockmoo Score
-1.4
| Analyst Consensus | -0.5 |
| Insider Activity | -1.5 |
| Price Volatility | -1.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -2.5 |
| Average | -1.40 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Core |
| % Held by Insiders | 0.91% |
| % Held by Institutions | 86.67% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 90.00 (B of A Securities, 28.98%) | Buy |
| 90.00 (Goldman Sachs, 28.98%) | Buy | |
| Median | 78.00 (11.78%) | |
| Low | 60.00 (Wolfe Research, -14.02%) | Sell |
| Average | 77.75 (11.42%) | |
| Total | 5 Buy, 6 Hold, 1 Sell | |
| Avg. Price @ Call | 71.53 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wolfe Research | 16 Jan 2025 | 60.00 (-14.02%) | Sell | 69.86 |
| B of A Securities | 16 Dec 2024 | 90.00 (28.98%) | Buy | 73.91 |
| Citigroup | 11 Dec 2024 | 83.00 (18.95%) | Buy | 73.81 |
| Canaccord Genuity | 05 Dec 2024 | 68.00 (-2.55%) | Hold | 72.43 |
| 25 Oct 2024 | 63.00 (-9.72%) | Hold | 69.38 | |
| Goldman Sachs | 05 Dec 2024 | 90.00 (28.98%) | Buy | 72.43 |
| RBC Capital | 05 Dec 2024 | 85.00 (21.81%) | Buy | 72.43 |
| 27 Nov 2024 | 80.00 (14.65%) | Buy | 72.07 | |
| Stifel | 05 Dec 2024 | 75.00 (7.48%) | Hold | 72.43 |
| Truist Securities | 05 Dec 2024 | 78.00 (11.78%) | Hold | 72.43 |
| 25 Oct 2024 | 70.00 (0.32%) | Hold | 69.38 | |
| Barclays | 02 Dec 2024 | 88.00 (26.11%) | Buy | 70.53 |
| Baird | 25 Oct 2024 | 68.00 (-2.55%) | Hold | 69.38 |
| JP Morgan | 25 Oct 2024 | 78.00 (11.78%) | Hold | 69.38 |
| Piper Sandler | 25 Oct 2024 | 70.00 (0.32%) | Hold | 69.38 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BOBO DONALD E JR | - | 69.86 | -5,000 | -349,300 |
| LIPPIS DANIEL J. | - | 69.86 | -500 | -34,930 |
| Aggregate Net Quantity | -5,500 | |||
| Aggregate Net Value ($) | -384,230 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 69.86 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LIPPIS DANIEL J. | Officer | 16 Jan 2025 | Automatic sell (-) | 500 | 69.86 | 34,930 |
| LIPPIS DANIEL J. | Officer | 16 Jan 2025 | Option execute | 500 | - | - |
| BOBO DONALD E JR | Officer | 16 Jan 2025 | Automatic sell (-) | 5,000 | 69.86 | 349,300 |
| BOBO DONALD E JR | Officer | 16 Jan 2025 | Option execute | 5,000 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |